Hematopoietic cell kinase (Hck) is a member of the Src family of non-receptor protein tyrosine kinases. High levels of Hck are associated with drug resistance in chronic myeloid leukemia. Furthermore, Hck activity has been connected with HIV-1. Herein, structure-based drug design efforts were aimed at identifying novel Hck inhibitors. First, an in-house library of pyrazolo[3,4-d]pyrimidine derivatives, which were previously shown to be dual Abl and c-Src inhibitors, was analyzed by docking studies within the A K-i values ranging from 0.14 to 18.4M, confirming the suitability of the computational approach adopted. Furthermore, selected compounds showed an interesting antiproliferative activity profile against the human leukemia cell line KU-812, and one compound was found to block HIV-1 replication at sub-toxic concentrations.

Identification of Hck Inhibitors As Hits for the Development of Antileukemia and Anti-HIV Agents / Cristina, Tintori; Ilaria, Laurenzana; F., La Rocca; Federico, Falchi; Fabio, Carraro; Alba, Ruiz; Jose A., Este; Miroslava, Kissova; Emmanuele, Crespan; Giovanni, Maga; Biava, Mariangela; Chiara, Brullo; Silvia, Schenone; Maurizio, Botta. - In: CHEMMEDCHEM. - ISSN 1860-7179. - 8:8(2013), pp. 1353-1360. [10.1002/cmdc.201300204]

Identification of Hck Inhibitors As Hits for the Development of Antileukemia and Anti-HIV Agents

BIAVA, Mariangela;
2013

Abstract

Hematopoietic cell kinase (Hck) is a member of the Src family of non-receptor protein tyrosine kinases. High levels of Hck are associated with drug resistance in chronic myeloid leukemia. Furthermore, Hck activity has been connected with HIV-1. Herein, structure-based drug design efforts were aimed at identifying novel Hck inhibitors. First, an in-house library of pyrazolo[3,4-d]pyrimidine derivatives, which were previously shown to be dual Abl and c-Src inhibitors, was analyzed by docking studies within the A K-i values ranging from 0.14 to 18.4M, confirming the suitability of the computational approach adopted. Furthermore, selected compounds showed an interesting antiproliferative activity profile against the human leukemia cell line KU-812, and one compound was found to block HIV-1 replication at sub-toxic concentrations.
2013
docking; hck; hiv-1; kinases; leukemia
01 Pubblicazione su rivista::01a Articolo in rivista
Identification of Hck Inhibitors As Hits for the Development of Antileukemia and Anti-HIV Agents / Cristina, Tintori; Ilaria, Laurenzana; F., La Rocca; Federico, Falchi; Fabio, Carraro; Alba, Ruiz; Jose A., Este; Miroslava, Kissova; Emmanuele, Crespan; Giovanni, Maga; Biava, Mariangela; Chiara, Brullo; Silvia, Schenone; Maurizio, Botta. - In: CHEMMEDCHEM. - ISSN 1860-7179. - 8:8(2013), pp. 1353-1360. [10.1002/cmdc.201300204]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/523387
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 21
social impact